ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

ClinicalTrials.gov ID: NCT07018323

Public ClinicalTrials.gov record NCT07018323. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 12:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves' Disease

Study identification

NCT ID
NCT07018323
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Immunovant Sciences GmbH
Industry
Enrollment
210 participants

Conditions and interventions

Interventions

  • IMVT-1402 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 18, 2025
Primary completion
Apr 30, 2027
Completion
Apr 30, 2027
Last update posted
Apr 21, 2026

2025 – 2027

United States locations

U.S. sites
33
U.S. states
15
U.S. cities
31
Facility City State ZIP Site status
Site Number - 1015 Tucson Arizona 85710 Recruiting
Site Number -1014 Concord California 94520 Recruiting
Site Number - 1013 Aurora Colorado 80045 Recruiting
Site Number - 1024 Doral Florida 33166 Recruiting
Site Number - 1008 Hialeah Florida 33016 Recruiting
Site Number - 1000 Miami Florida 33143 Recruiting
Site Number - 1020 Columbus Georgia 31904 Recruiting
Site Number - 1022 Topeka Kansas 66606 Recruiting
Site Number - 1030 Louisville Kentucky 40202 Recruiting
Site Number - 1033 Jefferson City Missouri 65109 Recruiting
Site Number - 1004 Kansas City Missouri 64110 Recruiting
Site Number - 1019 St Louis Missouri 63110 Recruiting
Site Number - 1012 Reno Nevada 89511 Recruiting
Site Number - 1032 Long Island City New York 11106 Recruiting
Site Number - 1027 New Hyde Park New York 11434 Recruiting
Site Number - 1009 New York New York 10022 Recruiting
Site Number - 1018 Williamsville New York 14221 Recruiting
Site Number - 1010 Chapel Hill North Carolina 27514 Recruiting
Site Number - 1026 Hickory North Carolina 28601 Recruiting
Site Number - 1001 Morehead City North Carolina 27577 Recruiting
Site Number - 1034 Raleigh North Carolina 27612 Recruiting
Site Number - 1007 Oklahoma City Oklahoma 73134 Recruiting
Site Number - 1017 Memphis Tennessee 38119 Recruiting
Site Number - 1029 Dallas Texas 75224 Recruiting
Site Number - 1002 El Paso Texas 79935 Recruiting
Site Number - 1003 Fort Worth Texas 76132 Recruiting
Site Number - 1031 Houston Texas 77030 Recruiting
Site Number - 1028 Houston Texas 77054 Recruiting
Site Number -1023 Irving Texas 75031 Recruiting
Site Number - 1021 Irving Texas 75039 Recruiting
Site Number - 1025 McKinney Texas 75069 Recruiting
Site Number - 1011 San Antonio Texas 78231 Recruiting
Site Number - 1016 Norfolk Virginia 23510 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07018323, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07018323 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →